CEO David Ricks got a 10% raise in 2024, as a surge in demand for weigh-loss drugs has propelled the pharma giant into the ...
Presiding over the upward trajectory of Eli Lilly over the last eight years is paying off nicely for CEO David Ricks. | ...
Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...
David Ricks, the CEO of Mounjaro and Zepbound maker Eli Lilly, explained why these medications are so expensive on the "In Good Company with Nicolai Tangen" podcast this week. 1. Time and money ...
RJ Luis Jr. is the Associated Press Big East player of the year and Rick Pitino’s a unanimous choice for coach of the year ...
Drugmakers want to capture a fair share of the value they create before patents expire, David Ricks said. The latest weight-loss drugs including Ozempic, Wegovy, Mounjaro, and Zepbound have list ...
Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to ...
The Palm Beach Post on MSN20d
After three years of delays, county takes over road work at two key intersectionsA legal quagmire developed after the contractor, Municipal Contractors Inc. of West Palm Beach, became insolvent, failing to ...
Eli Lilly Chief Executive David Ricks annual compensation rose to $29.2 million in 2024, a 10% increase from the $26.2 million he received a year earlier.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results